ImmuCell Corporation (ICCC)
NASDAQ: ICCC
· Real-Time Price · USD
5.15
-0.09 (-1.72%)
At close: May 13, 2025, 10:15 AM
ImmuCell Revenue
ImmuCell reported an annual revenue of $26.49M, reflecting a 51.64% growth. For the quarter ending December 31, 2024, ImmuCell generated $7.75M in revenue.
Revenue (ttm)
$26.49M
Revenue Growth
51.64%
Price / Sales Ratio
1.59
Revenue / Employee
$383.96K
Employees
69
Market Cap
46.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|